Complemented by biomarker tests for T4, Cortisol, CPSE, Progesterone and cCRP, Speed Reader is unique in that it is the ONLY in-clinic diagnostic biomarker test for CPSE, to screen dogs for Benign Prostatic Hyperplasia, of which 80% of intact male dogs over the age of 5 years old are at risk of developing.
Speed Reader provides practices with the opportunity to increase in-clinic diagnostic testing, reducing reliance on external laboratories, delivering immediate results and improving profitability. Offered with an intuitive touch screen user interface and integrated printer, Speed Reader tests can be performed in as little as 15 minutes using a simple step-by-step procedure displayed on the touch screen.
‘The Speed Reader biomarker range is a fantastic addition to Virbac’s diagnostic portfolio’ said Andrew Connolly, Marketing Director - UK & Ireland at Virbac. ‘Not only does Speed Reader offer practices improved in-clinic diagnostic testing, but having listened to customer feedback we are also offering Speed Reader with transparent, straightforward pricing and without complex commitment contracts.’
For more information on Speed Reader, or any of the other products in the Virbac diagnostic range, please speak to your Virbac Territory Manager.